Allergy Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Allergy Immunotherapy Market – Overview

This report studies the current as well as future prospects of the global allergy immunotherapy market. Stakeholders of the market include companies and intermediaries engaged in the manufacture, commercialization, and provision of immunotherapeutic drugs for treatment of allergy, as well as new players planning to enter the market. The report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. The section also provides overall information and data analysis of the global allergy immunotherapy market with respect to the leading market segments based on treatment type, allergy type, distribution channel, and region.

The global allergy immunotherapy market has been segmented based on treatment type, allergy type, distribution channel, and region. In terms of treatment type, the market has been classified into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). Based on allergy type, the global allergy immunotherapy market has been categorized into allergic rhinitis, asthma, food allergy, venom allergy, and others. In terms of distribution channel, the market has been divided into hospital pharmacies, retail pharmacies & drug stores, and online pharmacies.

Each of the market segments has been extensively analyzed based on market-related factors such as increase in incidence and prevalence of allergy. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, opportunities, and pipeline drugs that currently have a strong impact on the allergy immunotherapy market and are likely to influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors are expected to help market players take strategic decisions to strengthen their positions and enhance their shares in the global allergy immunotherapy market.

Geographically, the global allergy immunotherapy market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report provides market size and forecast for the major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and opportunities has been provided in the overview section. It also provides market attractiveness analysis and market share analysis of key players, thereby presenting a thorough examination of the overall competitive scenario of the global allergy immunotherapy market.

Major players operating in the global allergy immunotherapy market are Stallergenes Greer, Aimmune Therapeutics, ALK-Abello A/S, Allergy Therapeutics, Merck KGaA (Allergopharma), HAL Allergy Group, DBV Technologies, Circassia, Biomay AG, and Anergis.